NCT02643446已完成不适用
Serological Survey on Monitoring the Population Immunity and Positive Rate After Vaccination of Inactivated Poliovirus Vaccine
Centers for Disease Control and Prevention, China5 个研究点 分布在 1 个国家目标入组 809 人开始时间: 2015年8月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 809
- 试验地点
- 5
- 主要终点
- Seroconversion rate
研究概览
简要总结
The Purpose of this study is to assess the seroconversion using inactivated poliovirus vaccine (IPV) and oral poliovirus vaccine (OPV) sequential schedule in pilot areas where IPV was phased introduced into national immunization program (NIP) in China.
详细描述
Objective:
- To evaluate the seroprotection rates after the 3 doses of primary polio vaccination among age eligible children in pilot areas where the IPV was introduced into NIP;
- To evaluate the seroprotection rates after different dose(s) of polio vaccine(s) using sequential schedule.
Sample size:752
- Jilin shall select 120 subjects to collect blood samples for evaluation of immune response,of whom 90 will be given OPV as second vaccine and 30 will be given IPV as second vaccine
- Hubei shall select 132 subjects to collect blood samples for evaluation of immune response,of whom 102 will be given OPV as second vaccine and 30 will be given IPV as second vaccine
- Ningxia shall select 260 subjects to collect blood samples for evaluation of immune response. The subject will be divided into 5 groups.
- In Guangdong province,120 children will be selected as subjects , of whom 80 children will be given OPV as first vaccine and 40 children will be given IPV as first vaccine.
- Tianjin shall select 120 subjects to collect blood samples for evaluation of immune response, of whom 80 will be given OPV as second vaccine and 30 will be given IPV as second vaccine
Organization Chart of the Study:
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 2 Months 至 6 Months（Child）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Healthy children who are regular residents in the pilot counties where the immune response is evaluated in pilot provinces.
- •Receiving the polio vaccination at 2, 3 and 4 months old with an interval of 28-35 days between doses according to national immunization schedule. The first dose of vaccine was administered at 2 full months old and less than 3 full months old.
- •No rotavirus vaccine was administered during the period of primary polio vaccinations, and no vaccines of category 2 (private market) were administered simultaneously with polio vaccine. If vaccines of category 2 other than rotavirus vaccine were administered, they should be administered with a space of at least 2 weeks with polio vaccination.
排除标准
- •The first dose of polio vaccine was administered at more than 3 months old regardless of the reasons.
- •Children didn't get proper type and doses of vaccine as the protocal required.
- •Children with known immunodeficiency conditions.
- •Immunosuppressive agents or blood products were used after birth.
- •Vaccine contraindications.
结局指标
主要结局
Seroconversion rate
时间窗: One month after the specific dose of IPV or OPV
Calculate the percentage of subjects with seroconversion after each dose of IPV or OPV vaccination
次要结局
未报告次要终点
研究者
Huaqing Wang
Deputy Director, National Immunization Program, China CDC
Centers for Disease Control and Prevention, China
研究点 (5)
Loading locations...
相似试验
招募中
4 期
2DR Versus 3DR in a Prospective Randomized Controlled Switch TrialHIV-1-infectionNCT04553081University Hospital, Ghent134
已完成
1 期
Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine (Phase Ib)PolioNCT04264546Jiangsu Province Centers for Disease Control and Prevention60
已完成
4 期
A Safety Study of Sabin Inactivated Poliovirus Vaccine in InfantsPoliomyelitisNCT05432141Sinovac Biotech Co., Ltd3,200
已完成
4 期
Sero-conversion Study for a Two-dose Schedule of Sabin IPV in ChinaPoliomyelitisNCT03546634Centers for Disease Control and Prevention, China280
已完成
不适用
A Campaign-based ID fIPV Administration TrialPoliomyelitisNCT02967783Medical Research Council Unit, The Gambia2,721